CTI’s impact goes beyond delivering top-tier returns to our investors – Our portfolio companies have brought life-saving treatments to thousands of patients and fueled the growth of the local innovation ecosystem.
Years in business
Multiple funds raised
Investments
Therapeutic & Modality Agnostic
Regulatory approvals
10+ clinical trials
Companies created
Exits
40% hit rate
Jobs created
More than an investor - we are a Company Builder that catalyzes nascent ideas and assets into investable, scalable, and marketable biotech companies. The CTI advantages are:
Strategic buyers will pay a premium to acquire biotech companies with best-in-class assets or platform
Dual pronged approach that focuses on both long-term value creation and expedited exit timeline
Steer investments towards a meaningful exit by leveraging deep industry expertise and expansive network
An experienced team with a proven track record and the complementary skillset to take biotech investments from inception to inflection.
